Results 11 to 20 of about 10,897 (217)
Inflammatory demyelinating polyneuropathy after total hip arthroplasty
Arthroplasty Today, 2019 Inflammatory demyelinating polyneuropathy is a rare but devastating condition. Guillain-Barré syndrome is the most common cause with acute inflammatory demyelinating polyneuropathy being the most common subtype that follows a monophasic course and does ...
Shane R. Hess, DO +3 more
doaj +2 more sources
Steroids for Chronic Inflammatory Demyelinating Polyneuropathy
Pediatric Neurology Briefs, 2005 The efficacy and safety of high-dose, intermittent IV methylprednisolone (IVMP) as initial and long-term maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) were analyzed by a retrospective review of outcome data derived from
J Gordon Millichap
doaj +2 more sources
Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy [PDF]
Muscle & Nerve, 2015 ABSTRACTIntroductionSarcoid polyneuropathy is a rare and clinically heterogeneous disorder that may be the initial presentation of sarcoidosis.MethodsWe report the clinical, electrophysiological, and pathological findings of a patient who carried a diagnosis of sensory‐predominant chronic inflammatory demyelinating polyneuropathy (CIDP) for over a ...
Singhal, Neel S +3 more
openaire +6 more sources
Conductive hearing loss in chronic inflammatory demyelinating polyneuropathy (CIDP): A case report
Journal of Otology, 2018 Chronic inflammatory demyelinating polyneuropathy (CIDP) is a progressive autoimmune disorder that targets peripheral nerves. It commonly presents with motor-predominant dysfunction and enlargement of cranial nerves.
Mark A. Fadel +2 more
doaj +2 more sources
Chronic Inflammatory Polyneuropathy
Pediatric Neurology Briefs, 2007 Thirteen children with chronic inflammatory demyelinating polyneuropathy monitored between 1975 and 2005 are reported from Centre hospitalier universitaire Sainte-Justine, Montreal, Canada.
J Gordon Millichap
doaj +2 more sources
Biologics: Targets & Therapy, 2010 Mohamed Mahdi-Rogers, Yusuf A RajaballyNeuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester, UKAbstract: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired heterogeneous disorder of immune ...
Mohamed Mahdi-Rogers, Yusuf A Rajabally
doaj +1 more source
Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy [PDF]
Journal of Inflammation Research, 2020 Yusuf A Rajabally,1,2 Shahram Attarian,3,4 Emilien Delmont3,4 1Inflammatory Neuropathy Clinic, University Hospitals Birmingham, Birmingham, UK; 2Aston Medical School, Aston University, Birmingham, UK; 3Reference Centre for Neuromuscular Diseases and ALS,
Rajabally YA, Attarian S, Delmont E
doaj +2 more sources
The Electrophysiology of Disease Remission in Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]
Eur J NeurolElectrophysiological quasi‐normalisation may occur in a third of subjects with typical CIDP in clinical remission off treatment and may be more likely with prompt diagnosis/treatment. Electrophysiological amelioration may be observed in all tested nerves in CIDP in clinical remission off treatment.
Rajabally YA +4 more
europepmc +2 more sources
Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy
eNeurologicalSci, 2020 Treatment-related fluctuation (TRF), only defined in Guillain-Barre syndrome (GBS), refer to the deterioration of symptoms following treatment-induced improvement, and implies disease activity lasting beyond the effect of immunotherapy.
Young Gi Min, Yoon-Ho Hong
doaj +1 more source
Journal of Medical Case Reports, 2022 Background Autoantibodies targeting node of Ranvier proteins are rarely reported in China. Case presentation We present the case of a 66-year-old Chinese man who concomitantly developed chronic inflammatory demyelinating polyneuropathy with anti ...
Shurong Hu, Yin Hu, Qiang Du
doaj +1 more source